ZNO

0.00%

2.5¢ zoono group limited

Ann: Response to ASX Query Letter, page-3

First 3 Last

Share
Profile

Follow
Heisenberg63

2,034 Posts.

304

02/04/24

08:57

Post #: 73140942
Share

Originally posted by Happ: ↑

Firstly, congrats to those who managed to double their money or reduce the loss on this stock in the past month or so.

The letter to ASX puts the directors on the hook of regulatory action with some severe consequences in the event that they spun the bullshit.

Although I am open to the possibility that the company will make it through and be successful my bullshit radar is spitting a few things out:

1. For them to pay a start up (OSY) to essentially move the stock shows incredibly weak their bargaining position was = how desperate they are.

2. Ditto regarding minimum sales. Unenforceable as usual. Shows that it's a pure punt for OSY.

3. Share price at 12c = fully diluted valuation $38mln. How the f*ck can this be valued at that much is beyond any rationale. It appears that the broker / partial underwriter is making sure they make a motza on this. Driving price higher to entice shareholders to participate and driving it high enough so that t e underwriter can actually sell stock on market once the share price starts falling and still make money.

As always great salesmanship by Hyslop. You have to admit he's talented and tenacious. Really could have applied his talents selling electric cars or something.

I would not touch it and if I held I would use every opportunity to sell at these levels before it crashes down. At 2.7c offer it would be valued at $10mln. It will get there again.

Expand

Lol I traded a small parcel for a pip last week..
Seems momentum has burned out fast.
You saying it's reached a short term top?

ZNO Price at posting: 12.0¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 3 more messages in this thread...

First 3 Last

Add ZNO (ASX) to my watchlist

(20min delay)
Last 2.5¢		Change 0.000(0.00%)		Mkt cap ! $8.885M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	180000	2.6¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	73700	2

View Market Depth

No.	Vol.	Price($)
1	180000	0.026
4	209233	0.025
1	154528	0.024
1	39000	0.023
4	206322	0.022

Price($)	Vol.	No.
0.028	73700	2
0.029	304864	1
0.030	31000	2
0.031	32096	1
0.032	139295	2

Last trade - 16.12pm 04/10/2024 (20 minute delay)

ZNO (ASX) Chart

Day chart unavailable

Ann: Response to ASX Query Letter, page-3

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Response to ASX Query Letter, page-3

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News